Comparisons of in Vitro Models to Evaluate the Membrane Permeability of Amorphous Drug Nanoparticles.
暂无分享,去创建一个
Na Li | A. Narula | Rayan Sabra | L. Taylor
[1] Geoff G. Z. Zhang,et al. Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone , 2022, Pharmaceutical Research.
[2] David J Brayden,et al. Best practices in current models mimicking drug permeability in the gastrointestinal tract - an UNGAP review. , 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[3] L. S. Taylor,et al. A mechanistic study of drug mass transport from supersaturated solutions across PAMPA membranes. , 2021, Journal of pharmaceutical sciences.
[4] Harjinder Singh,et al. Comparing the permeability of human and porcine small intestinal mucus for particle transport studies , 2020, Scientific Reports.
[5] P. Bummer,et al. Towards Developing Discriminating Dissolution Methods for Formulations Containing Nano-Particulates in Solution; The Impact of Particle Drift and Drug Activity in Solution. , 2020, Molecular pharmaceutics.
[6] L. S. Taylor,et al. Impact of hypromellose acetate succinate grade on drug amorphous solubility and in vitro membrane transport. , 2020, Journal of pharmaceutical sciences.
[7] H. Katsumi,et al. Comparison of Various Cell Lines and Three-Dimensional Mucociliary Tissue Model Systems to Estimate Drug Permeability Using an In Vitro Transport Study to Predict Nasal Drug Absorption in Rats , 2020, Pharmaceutics.
[8] Kazunori Kadota,et al. The elucidation of key factors for oral absorption enhancement of nanocrystal formulations: In vitro - in vivo correlation of nanocrystals. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[9] Michael E. Grass,et al. A practical approach to modeling the impact of amorphous drug nanoparticles on the oral absorption of poorly soluble drugs. , 2019, Molecular pharmaceutics.
[10] W. Xu,et al. Effect of Amorphous Nanoparticle Size on Bioavailability of Anacetrapib in Dogs. , 2019, Journal of pharmaceutical sciences.
[11] P. Snyder,et al. Overcoming the Bile Salt-Mediated Formation of Nanocolloids That Inhibit Oral Absorption of VX-985. , 2019, Journal of pharmaceutical sciences.
[12] L. S. Taylor,et al. Insight into Amorphous Solid Dispersion Performance by Coupled Dissolution and Membrane Mass Transfer Measurements. , 2018, Molecular pharmaceutics.
[13] Geoff G. Z. Zhang,et al. Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[14] B. Riebesehl,et al. Ranking Itraconazole Formulations Based on the Flux through Artificial Lipophilic Membrane , 2018, Pharmaceutical Research.
[15] L. S. Taylor,et al. Absorptive Dissolution Testing of Supersaturating Systems: Impact of Absorptive Sink Conditions on Solution Phase Behavior and Mass Transport. , 2017, Molecular pharmaceutics.
[16] H. Lennernäs,et al. In Vivo Mechanisms of Intestinal Drug Absorption from Aprepitant Nanoformulations. , 2017, Molecular pharmaceutics.
[17] M. Morgen,et al. Impact of Drug-Rich Colloids of Itraconazole and HPMCAS on Membrane Flux in Vitro and Oral Bioavailability in Rats. , 2017, Molecular pharmaceutics.
[18] M. Morgen,et al. Development of a Biorelevant, Material-Sparing Membrane Flux Test for Rapid Screening of Bioavailability-Enhancing Drug Product Formulations. , 2017, Molecular pharmaceutics.
[19] J. Litster,et al. Impact of Endogenous Bile Salts on the Thermodynamics of Supersaturated Active Pharmaceutical Ingredient Solutions , 2017 .
[20] Geoff G. Z. Zhang,et al. Exploiting the Phenomenon of Liquid-Liquid Phase Separation for Enhanced and Sustained Membrane Transport of a Poorly Water-Soluble Drug. , 2016, Molecular pharmaceutics.
[21] H. Katsumi,et al. Importance of the Direct Contact of Amorphous Solid Particles with the Surface of Monolayers for the Transepithelial Permeation of Curcumin. , 2016, Molecular pharmaceutics.
[22] Jingbo Liu,et al. Optimization of Caco-2 and HT29 co-culture in vitro cell models for permeability studies , 2015, International journal of food sciences and nutrition.
[23] L. S. Taylor,et al. pH-Dependent Liquid-Liquid Phase Separation of Highly Supersaturated Solutions of Weakly Basic Drugs. , 2015, Molecular pharmaceutics.
[24] J. Tack,et al. Evaluation of fasted and fed state simulated and human intestinal fluids as solvent system in the Ussing chambers model to explore food effects on intestinal permeability. , 2015, International journal of pharmaceutics.
[25] Mandy B. Esch,et al. TEER Measurement Techniques for In Vitro Barrier Model Systems , 2015, Journal of laboratory automation.
[26] L. S. Taylor,et al. Glass-liquid phase separation in highly supersaturated aqueous solutions of telaprevir. , 2015, Molecular pharmaceutics.
[27] M. Brandl,et al. What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion? , 2014, Journal of pharmaceutical sciences.
[28] L. S. Taylor,et al. Influence of additives on the properties of nanodroplets formed in highly supersaturated aqueous solutions of ritonavir. , 2013, Molecular pharmaceutics.
[29] P. Tso,et al. Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation. , 2013, Molecular pharmaceutics.
[30] L. S. Taylor,et al. Liquid–Liquid Phase Separation in Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs: Implications for Solubility Enhancing Formulations , 2013 .
[31] Ian A. Watson,et al. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux. , 2013, Molecular pharmaceutics.
[32] L. Benet,et al. Drug Discovery and Regulatory Considerations for Improving In Silico and In Vitro Predictions that Use Caco-2 as a Surrogate for Human Intestinal Permeability Measurements , 2013, The AAPS Journal.
[33] A. Dahan,et al. The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations. , 2012, Molecular pharmaceutics.
[34] Lynne S Taylor,et al. Dissolution and precipitation behavior of amorphous solid dispersions. , 2011, Journal of pharmaceutical sciences.
[35] Kiyohiko Sugano,et al. Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect. , 2010, International journal of pharmaceutics.
[36] Gretchen J. Mahler,et al. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability. , 2009, The Journal of nutritional biochemistry.
[37] Claus-Michael Lehr,et al. Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[38] Paul J Lewi,et al. Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability. , 2005, Journal of medicinal chemistry.
[39] David J Brayden,et al. In Vitro Models of the Intestinal Barrier , 2001, Alternatives to laboratory animals : ATLA.
[40] R T Borchardt,et al. Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size. , 1997, Journal of pharmaceutical sciences.
[41] K. D. Fine,et al. Effect of changing intestinal flow rate on a measurement of intestinal permeability. , 1995, Gastroenterology.
[42] P. Artursson,et al. Mechanisms of absorption enhancement and tight junction regulation , 1994 .
[43] T. Kondo,et al. Kinetic model for membrane transport. III. Solute transport through an asymmetrical membrane , 1992 .
[44] Thomas J. Raub,et al. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. , 1989, Gastroenterology.
[45] P. Augustijns,et al. Assessment of Passive Intestinal Permeability Using an Artificial Membrane Insert System. , 2018, Journal of pharmaceutical sciences.
[46] C. Teng,et al. Systematic studies on the paracellular permeation of model permeants and oligonucleotides in the rat small intestine with chenodeoxycholate as enhancer. , 2008, Journal of pharmaceutical sciences.
[47] Alex Avdeef,et al. Absorption and drug development , 2003 .
[48] O. Corrigan,et al. Retardation of Polymeric Carrier Dissolution by Dispersed Drugs: Factors Influencing the Dissolution of Solid Dispersions Containing Polyethlene Glycols , 1986 .
[49] G. Amidon,et al. Theoretical and experimental studies of transport of micelle-solubilized solutes. , 1982, Journal of pharmaceutical sciences.